Prophylactic is one of 8 small molecule programs targeting Ventral Hernia. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
8 competitors in Ventral Hernia
Marcaine
Botox
Robaxin
AGN-151607-DP
Entereg
Naropin
Bupivicaine
Prophylactic
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources